← Browse by Condition
Medical Condition

urinary bladder overactive

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for urinary bladder overactive sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — urinary bladder overactive Clinical Trials

How many clinical trials are currently recruiting for urinary bladder overactive?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for urinary bladder overactive, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for urinary bladder overactive?
urinary bladder overactive research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a urinary bladder overactive clinical trial?
Eligibility criteria for urinary bladder overactive trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Bright Uro 1 trial
Mackay Memorial Hospital 1 trial
Children's Hospital of Chongqing Medical University 1 trial

Recruiting Clinical Trials

NCT07425015
Recruiting
Ambulatory Long Length URodynamics Evaluation
Enrollment
101 pts
Location
United States
Sponsor
Bright Uro
View Trial →
NCT06197295 Phase 4
Recruiting
Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity
Enrollment
200 pts
Location
Taiwan
Sponsor
Mackay Memorial Hospital
View Trial →
NCT06201013
Recruiting
Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet
Enrollment
180 pts
Location
China
Sponsor
Children's Hospital of Chongqi...
View Trial →

Related Conditions

urology (1) benign prostatic hyperplasia (1) urodynamics (1) home monitoring (1) urinary incontinence ui (1) lower urinary tract dysfunction (1) effect of drug (1) overactive bladder (1) urinary incontinence urge (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology